Key rates for the grades and transformation ability of glioma: model simulations and clinical cases

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Neuro-Oncology

• Publication date

  2017-04-27

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s11060-017-2444-6PMID 28451993
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Single Cell Mathematical Model Successfully Replicates Key Features of GBM: Go-Or-Grow Is Not Necessary

  2017cited by this paper
• ATRX loss promotes tumor growth and impairs nonhomologous end joining DNA repair in glioma

  2016cited by this paper
• ATRX mutations and glioblastoma: Impaired DNA damage repair, alternative lengthening of telomeres, and genetic instability

  2016cited by this paper
• ATRX loss in adult supratentorial diffuse astrocytomas correlates with p53 over expression and IDH1 mutation and predicts better outcome in p53 accumulated patients.

  2016cited by this paper
• Immunohistochemistry on IDH 1/2, ATRX, p53 and Ki-67 substitute molecular genetic testing and predict patient prognosis in grade III adult diffuse gliomas

  2016cited by this paper
• R132H mutation in IDH1 gene reduces proliferation, cell survival and invasion of human glioma by downregulating Wnt/β-catenin signaling.

  2016cited by this paper
• ATRX immunostaining predicts IDH and H3F3A status in gliomas

  2016cited by this paper
• ATRX, IDH1-R132H and Ki-67 immunohistochemistry as a classification scheme for astrocytic tumors

  2016cited by this paper
• Resistance to DNA Damaging Agents Produced Invasive Phenotype of Rat Glioma Cells—Characterization of a New in Vivo Model

  2016cited by this paper
• Computational Trials: Unraveling Motility Phenotypes, Progression Patterns, and Treatment Options for Glioblastoma Multiforme

  2016cited by this paper
• Phenotypic Transition as a Survival Strategy of Glioma

  2016cited by this paper
• Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma.

  2016cited by this paper
• Inhibition of radiation-induced glioblastoma invasion by genetic and pharmacological targeting of MDA-9/Syntenin

  2016cited by this paper
• Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitors

  2015cited by this paper
• Integrated genomic characterization of IDH1-mutant glioma malignant progression

  2015cited by this paper
• The Evolving Molecular Genetics of Low-grade Glioma

  2015cited by this paper
• IDH mutation, 1p19q codeletion and ATRX loss in WHO grade II gliomas

  2015cited by this paper
• Loss of ATRX, associated with DNA methylation pattern of chromosome end, impacted biological behaviors of astrocytic tumors

  2015cited by this paper
• Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.

  2015cited by this paper
• Targeting adaptive glioblastoma: an overview of proliferation and invasion.

  2014cited by this paper
• Effects of Anti-Angiogenesis on Glioblastoma Growth and Migration: Model to Clinical Predictions

  2014cited by this paper
• Progression types after antiangiogenic therapy are related to outcome in recurrent glioblastoma

  2014cited by this paper
• An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells

  2013cited by this paper
• Reciprocal Activation of Transcription Factors Underlies the Dichotomy between Proliferation and Invasion of Glioma Cells

  2013cited by this paper
• c-Src and Neural Wiskott-Aldrich Syndrome Protein (N-WASP) Promote Low Oxygen-Induced Accelerated Brain Invasion by Gliomas

  2013cited by this paper
• Loss of ATRX, Genome Instability, and an Altered DNA Damage Response Are Hallmarks of the Alternative Lengthening of Telomeres Pathway

  2012cited by this paper
• The Definition of Primary and Secondary Glioblastoma

  2012cited by this paper
• 'Go or grow': the key to the emergence of invasion in tumour progression?

  2012cited by this paper
• IDH mutation impairs histone demethylation and results in a block to cell differentiation

  2012cited by this paper
• p53-responsive miR-194 inhibits thrombospondin-1 and promotes angiogenesis in colon cancers.

  2011cited by this paper
• IDH1 R132H decreases proliferation of glioma cell lines in vitro and in vivo

  2011cited by this paper
• Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes.

  2011cited by this paper
• A novel pre-clinical in vivo mouse model for malignant brain tumor growth and invasion

  2010cited by this paper
• Assaying and investigating Alternative Lengthening of Telomeres activity in human cells and cancers

  2010cited by this paper
• P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis

  2010cited by this paper
• IDH1 and IDH2 mutations in gliomas.

  2009cited by this paper
• Macrophage Migration Inhibitory Factor Activates Hypoxia-Inducible Factor in a p53-Dependent Manner

  2008cited by this paper
• The clinical value of Ki-67/MIB-1 labeling index in human astrocytomas

  2008cited by this paper
• An Integrated Genomic Analysis of Human Glioblastoma Multiforme

  2008cited by this paper
• The 2007 WHO Classification of Tumours of the Central Nervous System

  2007cited by this paper
• Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progression

  2007cited by this paper
• Chromosome instability, chromosome transcriptome, and clonal evolution of tumor cell populations

  2007cited by this paper
• Inhibition of p53 response in tumor stroma improves efficacy of anticancer treatment by increasing antiangiogenic effects of chemotherapy and radiotherapy in mice.

  2006cited by this paper
• Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas.

  2005cited by this paper
• Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

  2005cited by this paper
• A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas.

  2005cited by this paper
• Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas

  2004cited by this paper
• Ki-67 immunoreactivity in human central nervous system tumors: a study with MIB 1 monoclonal antibody on archival material

  2004cited by this paper
• Invasive phenotype observed in 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant sublines of 9L rat glioma cells: a tumor model mimicking a recurrent malignant glioma.

  2004cited by this paper
• MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.

  2004cited by this paper
• Effects of tumor suppressor gene (p53) on brain tumor angiogenesis and expression of angiogenic modulators.

  2004cited by this paper
• Overexpression of the p53-inducible brain-specific angiogenesis inhibitor 1 suppresses efficiently tumour angiogenesis

  2002cited by this paper
• Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression.

  2000cited by this paper
• Wild-type p53 gene transfer inhibits invasion and reduces matrix metalloproteinase-2 levels in p53-mutated human melanoma cells.

  2000cited by this paper
• Survival rates for primary malignant brain tumours in Europe. EUROCARE Working Group.

  1998cited by this paper
• Dichotomy of astrocytoma migration and proliferation

  1996cited by this paper
• Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression.

  1995cited by this paper
• Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells

  1994cited by this paper
• Clonal expansion of p53 mutant cells is associated with brain tumour progression

  1992cited by this paper
• A population‐based study on the incidence and survival rates of 3857 glioma patients diagnosed from 1953 to 1984

  1991cited by this paper
• Long-term survival after malignant glioma. A clinical and histopathological study on the accuracy of the diagnosis in a population-based cancer register.

  1990cited by this paper
• Tumor suppressor genes: the puzzle and the promise.

  1989cited by this paper
• Incidence and Survival of Brain Tumors: A Population-Based Study

  1988cited by this paper
• Inhibition of cell growth mediated by plasmids encoding p53 anti-sense.

  1987cited by this paper
• Participation of p53 cellular tumour antigen in transformation of normal embryonic cells

  1984cited by this paper
• Cellular immortalization by a cDNA clone encoding the transformation-associated phosphoprotein p53

  1984cited by this paper

• Prognostic histopathologic features of canine glial tumors

  2021cites this paper
• Spatial distribution of malignant transformation in patients with low-grade glioma

  2020cites this paper
• The landscape of postsurgical recurrence patterns in diffuse low-grade gliomas.

  2019cites this paper
• Diagnosing growth in low-grade gliomas with and without longitudinal volume measurements: A retrospective observational study

  2019cites this paper
• Nonlinear Brain Tumor Model Estimation with Long Short-Term Memory Neural Networks

  2018cites this paper